![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1527046
¼¼°èÀÇ ±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛ ½ÃÀå(2024-2031³â)Global Optical Imaging Systems Market 2024-2031 |
±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°(À̹Ì¡ ½Ã½ºÅÛ, ±¤ÇÐ À̹Ì¡ ¼ÒÇÁÆ®¿þ¾î, Á¶¸í ½Ã½ºÅÛ), ¿ëµµº°(¾È°ú, Ä¡°ú, ÇǺΰú, ¼øÈ¯±â°ú, ½Å°æ°ú, Á¾¾ç°ú, »ý¸í°øÇÐ, ¿¬±¸, ±âŸ), ±â¼úº°(±¤ ÄÚÈ÷¾î·±½º ½ºÅä¸ð±×·¡ÇÇ, ±ÙÀû¿Ü ºÐ±¤¹ý, ÇÏÀÌÆÛ ½ºÆåÆ®·³ À̹Ì¡, ±¤À½Çâ Åä¸ð±×·¡ÇÇ), ÃÖÁ¾ »ç¿ëÀÚº°(¿µ»ó Áø´Ü¼¾ÅÍ, º´¿ø ¹× Ŭ¸®´Ð, ¿¬±¸¼Ò) ¿¹Ãø ±â°£(2024³â- 2031³â)
±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È(2024-2031³â) º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 11.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛÀº ±¤ ÄÚÈ÷¾î·±½º ½ºÅä¸ð±×·¡ÇÇ(OCT), ±¤ À½Çâ À̹Ì¡, ±ÙÀû¿Ü¼± ºÐ±¤¹ý µîÀÇ À̹Ì¡ ±â¼úÀÇ ¹ßÀüÀ¸·Î Á¡Á¡ ´ëÁßȵǰí ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ´« Áúȯ°ú ½ÉÇ÷°ü ÁúȯÀÇ Áø´Ü°ú ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÒ»Ó¸¸ ¾Æ´Ï¶ó Á¾¾çÇÐ ºÐ¾ß¿¡¼ ¾ÏÀÇ Á¶±â ¹ß°ßÀ» ¿ëÀÌÇϰÔÇÕ´Ï´Ù. ºñħ½ÀÀû Áø´Ü¹ýÀÇ ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø Áõ°¡´Â ¼¼°è »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡
½ÉÇ÷°ü Áúȯ, ¾Ï, ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¶±â ¹ß°ß°ú È¿°úÀûÀÎ Ä¡·á °èȹÀ» À§ÇØ ±¤ À̹Ì¡ ½Ã½ºÅÛ°ú °°Àº °í±Þ Áø´Ü µµ±¸¸¦ »ç¿ëÇØ¾ßÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 2023³â 9¿ù ¸¸¼ºÁúȯÀº ¼¼°è »ç¸ÁÀÚ ¼öÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí, ¸Å³â 4,100¸¸¸íÀÌ »ç¸ÁÇϰí, ¼¼°è Àüü »ç¸ÁÀÚ ¼öÀÇ 74.0%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ç½ÇÀº ½ÉÇ÷°ü Áúȯ(¿¬°£ »ç¸ÁÀÚ ¼ö 1,790¸¸¸í), ¾Ï(»ç¸ÁÀÚ ¼ö 930¸¸¸í), ¸¸¼º È£Èí±â Áúȯ(»ç¸ÁÀÚ ¼ö 410¸¸¸í), »ç¸Á »ç°í(´ç´¢º´¿¡ ÀÇÇÑ ½ÅÀ庴À» Æ÷ÇÔµÈ »ç¸ÁÀÚ ¼ö 200¸¸¸í)¿Í °°Àº ÁÖ¿ä ¸¸¼º Áúȯ¿¡ ´ëÇÑ ´ëó°¡ ½Ã±ÞÇÏ´Ù´Â °ÍÀ» ³ªÅ¸³»°í ÀÖ½À´Ï´Ù.
³ë³â Àα¸ Áõ°¡
³ë³â Àα¸´Â Ȳ¹Ý º¯¼ºÁõ°ú ¹é³»Àå°ú °°Àº ³ëÈ¿Í °ü·ÃµÈ Áúº´¿¡ °É¸®±â ½±½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2022³â 10¿ù ¼¼°è 60¼¼ ÀÌ»óÀÇ Àα¸´Â 21¾ï ¸íÀ¸·Î Å©°Ô Áõ°¡ÇßÀ¸¸ç 80¼¼ ÀÌ»óÀÇ Àα¸´Â 3¹èÀÎ 4¾ï 2600¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹Ãø ÀÖ½À´Ï´Ù. µû¶ó¼ ³ëÀÎ Àα¸ Áõ°¡´Â ¸¸¼º ÁúȯÀÇ Á¶±â Áø´ÜÀ» À§ÇÑ ±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÃÀå ¼¼ºÐÈ
¾Ï ¿µ¿ªÀÌ ÃÖ´ë ºÎ¹®ÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù.
¾Ï ȯÀÚ ¼ö Áõ°¡, ÁøÇà ÁßÀÎ Á¾¾çÇÐ ¿¬±¸ ¹× ÀÓ»ó½ÃÇè, ¾Ï Á¶±â Áø´Ü ¹× ¿ÂŸÀÓ Ä¡·á¸¦ À§ÇÑ °í±Þ ±¤ À̹Ì¡ ½Ã½ºÅÛÀÇ °³¹ßÀÌ ÀÌ ½ÃÀå ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. Àü¹Ì À¯¹æ¾Ï Àç´Ü¿¡ µû¸£¸é 2024³â 4¿ù ¹Ì±¹¿¡¼´Â À¯¹æ¾ÏÀÌ »ó´ç¼öÀÇ °³ÀÎÀ» ¾Î°í ¿©¼ºÀÇ ¾à 8¸í Áß 1¸íÀÌ º´À» ¾Î°í ³²¼ºÀÇ º´ ȯÀÚ¼ö´Â ±×º¸´Ù Àû½À´Ï´Ù. 2024³â¿¡´Â ¿©¼º 310,720¸í, ³²¼º 2,800¸íÀÌ Ä§À±¼º À¯¹æ¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ±¤ÇÐ À̹Ì¡ ½Ã½ºÅÛ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º ¹× ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), ¼¼°è ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¶óƾ ¾Æ¸Þ¸®Ä«)À» Æ÷ÇÔÇÑ Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.
ºÏ¹Ì¿¡¼ÀÇ ±¤ÇÐ À̹Ì¡ ±â¼úÀÇ ¹ßÀü
ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº ÇØ»óµµ, °¨µµ, ¼ÓµµÀÇ Çâ»ó µî ±¤ÇÐ À̹Ì¡ ±â¼úÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù, Fujifilm Healthcare Americas Corp.´Â ºÏ¹Ì ¹æ»ç¼± ÇÐȸ(RSNA) ¿¬·Ê ÃÑȸ¿¡¼ »õ·Î¿î ÀÇ·á ½Ã½ºÅÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ È¸»ç´Â µðÁöÅÐ X ¼± ÃÔ¿µ ÀåÄ¡, Åõ½Ã ½Ã½ºÅÛ, 0.4T MRI ½Ã½ºÅÛ, 128 ½½¶óÀ̽º CT ½Ã½ºÅÛÀ» º¸À¯Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¿¢½º·¹ÀÌ ½ºÄµÀ» ´Ü¼øÈÇϰí, ÀϰüµÇ°í È¿À²ÀûÀÎ °Ë»ç¸¦ Á¦°øÇϸç, °Ë»ç¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ´Ü¼øÈÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ÁÖ¿ä ½ÃÀå Á¡À¯À²À» Â÷Áö
³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ ³ô¾ÆÁö¸é¼ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ̵Ǿú½À´Ï´Ù. Á¤ºÎ Åë°è¿¡ µû¸£¸é 2024³â 1¿ù Áß±¹ 60¼¼ ÀÌ»ó Àα¸´Â ¾à 2¾ï 9,700¸¸ ¸íÀ¸·Î ÃÑ Àα¸ÀÇ 21.1%¸¦ Â÷ÁöÇÕ´Ï´Ù. Áö¿ª Àü¹Ý¿¡ °ÉÃÄ °Ç° °ü¸® ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áö¿ª ½ÃÀå ¼ºÀåÀÌ ´õ¿í °ÈµÇ°í ÀÖ½À´Ï´Ù.
Optical Imaging Systems Market Size, Share & Trends Analysis Report by Product (Imaging Systems, Optical Imaging Software, and Illumination Systems), by Application (Ophthalmology, Dentistry, Dermatology, Cardiology, Neurology, Oncology, Biotechnology and Research, and Others), by Technique (Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging, and Photoacoustic Tomography), and by End-User (Diagnostic Imaging Center, Hospitals and Clinics, and Research Laboratories) Forecast Period (2024-2031)
Optical imaging systems market is anticipated to grow at a CAGR of 11.4% during the forecast period (2024-2031). Optical imaging systems have become increasingly popular with advancements in imaging techniques such as optical coherence tomography (OCT), photoacoustic imaging, and near-infrared spectroscopy. These systems play an essential role in diagnosing and monitoring eye and cardiovascular diseases, as well as facilitating early cancer detection in the oncology field. The increased funding for R&D of non-invasive diagnostic procedures is a key factor driving the global industry growth.
Market Dynamics
Growing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as cardiovascular disease, cancer, and diabetes necessitates the use of advanced diagnostic tools like optical imaging systems for early detection and effective treatment planning. According to the World Health Organisation, in September 2023, chronic diseases were responsible for a significant number of global mortalities, with 41 million individuals mortality each year, accounting for 74.0% of all mortalities globally. These facts depict the urgency to address the major chronic diseases, such as cardiovascular diseases (17.9 million mortalities annually), cancers (9.3 million mortalities), chronic respiratory diseases (4.1 million mortalities), and mortalities (2.0 million deaths, including kidney disease caused by diabetes).
Increasing Geriatric Population
The geriatric population is highly susceptible to age-related diseases such as macular degeneration and cataracts. According to the World Health Organization (WHO), in October 2022, the global population of individuals aged 60 years and older is projected to increase significantly to 2.1 billion, with the number of individuals aged 80 years or older expected to triple to reach 426.0 million. Therefore, the growing geriatric population is anticipated to drive the demand for optical imaging systems for early diagnosis of chronic disorders.
Market Segmentation
Oncology is Projected to Emerge as the Largest Segment
The increasing number of cancer cases, ongoing oncology research and clinical trials, and the development of advanced optical imaging systems for the early diagnosis and on-time treatment of cancer are key factors driving this market segment's growth. According to the National Breast Cancer Foundation, in April 2024, breast cancer affects a significant number of individuals in the US, with approximately 1 in 8 women and a smaller number of men being diagnosed with the disease. In 2024, it is projected that 310,720 women and 2,800 men will receive a diagnosis of invasive breast cancer.
The global optical imaging systems market is segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Technological Advancements in Optical Imaging Technologies in North America
The regional market growth is driven by continuous technological advancements in optical imaging technologies such as improvements in resolution, sensitivity, and speed across the region. For instance, in November 2023, Fujifilm Healthcare Americas Corp. launched new medical systems at the Radiological Society of North America's (RSNA) annual meeting. The company possesses digital radiography suites, fluoroscopy systems, a 0.4T MRI system, and a 128-slice CT system. These systems aim to simplify X-ray scans, deliver consistent, efficient exams, and simplify exam access.
Asia-Pacific Holds Major Market Share
The high prevalence of chronic disorders with the growing geriatric population is a key factor driving the growth of the regional market. According to government statistics, in January 2024, China's population aged 60 and above accounted for approximately 297 million individuals in 2023, which represents 21.1% of the total population. The increasing healthcare expenditure across the region is further aiding the regional market growth.
The major companies serving the optical imaging systems market include Abbott Laboratories, Carl Zeiss AG, GE HealthCare Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in February 2024, Bruker Corp. acquired Spectral Instruments Imaging, a provider of preclinical in-vivo optical imaging systems. The acquisition fills a gap in the Bruker BioSpin Preclinical Imaging division, expanding its range of preclinical solutions for disease research.